Colour enhancement

From PsychonautWiki
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Pramiracetam
Experience:1000 Morning Glory seeds - Rediscovering the Self
4-HO-DiPT
JWH-018
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
JWH-073
LSA
25C-NBOMe
3-MeO-PCE
Allylescaline
MDAI
4-FA
1P-ETH-LAD
4-HO-DET
5F-PB-22
Experience:300µg AL-LAD - Don't worry, because you're everyone!
4-AcO-MiPT
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
EPT
Methallylescaline
Psilocin
Experience:3-MeO-PCP - Extreme psychosis
6-APDB
Oxiracetam
Escaline
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:1mg 25c-NBOMe - Experiment in my room
Pregabalin
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
GABAergic hallucinogens
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Experience:800 seeds LSA - My First Trip Ever
Experience:BK-2C-B - Various experiences
Experience:25mg 3-MeO-PCP - Enhanced film experience
5-MeO-DiPT
25C-NBOH
2C-B-FLY
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
MDMA
4-AcO-DiPT
Amanita muscaria
4-HO-MiPT
DET
Aniracetam
3-MMC
4-AcO-DMT
2C-T-7
Ibogaine
4-HO-EPT
Experience:300µg LSD - Togetherness and the Silent Dusk
4-AcO-DET
DOC
Enhancement of colour rose.jpgRose by Chelsea Morgan
2C-T-21
MET
25D-NBOMe
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
MiPT
2C-C
2C-I
Phenylpiracetam
PRO-LAD
1B-LSD
LSD
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
25N-NBOMe
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Efavirenz
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
Ayahuasca
5-MeO-MiPT
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:120mg - Garden of The Gods
ETH-LAD
Experience:40mg - Brothermind and the Forest's Hand
DOB
MPT
25I-NBOH
Experience:4x 200ug tabs - You do not need to understand
DMT
3C-E
5-MeO-DALT
25B-NBOMe
Mescaline
Experience:337mg DMT fumarate - A Day With DMT
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
Bromo-DragonFLY
Chameleon.jpgChameleon by Anonymous.
Proscaline
LSZ
2C-D
MDA
DOI
MiPLA
4-HO-DPT
1P-LSD
Experience:4-HO-MiPT / A care free psychedelic getaway
LSM-775
Bufotenin
Chur City in Switzerland.jpgChur, Switzerland by Naps284
THJ-2201
DPT
Piracetam
4-AcO-MET
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
Experience:25mg Deschloroketamine - My first time orally dosing DCK
MDEA
Omberacetam
6-APB
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Experience:250mg DXM - DXM Itch and Trip Report
TMA-2
Memantine
2C-P
Selective serotonin reuptake inhibitor
25I-NBOMe
Psilocybin mushrooms
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
ALD-52
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
Experience:3g mimosa / 3g syrian rue - Connecting with my body
Phenethylamine (compound)
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:4.5g - The Grand Introduction to Beauty and Fear
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
AL-LAD
TMA-6
25B-NBOH
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
Βk-2C-B
4-HO-MET
ΑMT
2C-H
5-MeO-DiBF
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
2C-E
Experience:2 tabs DOB - My DOB Nightmare
5-Hydroxytryptophan
2C-T-2
DiPT
4-HO-MPT
PARGY-LAD
THJ-018
Tree.jpgJapanese Garden by Anonymous
2C-B

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.